Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis

BACKGROUND: Recently, ocrelizumab (Ocrevus®) was approved for the treatment of primary progressive multiple sclerosis (PPMS) based on data from the ORATORIO clinical trial. Real-world data about the clinical effectiveness of ocrelizumab has yet to be gathered. OBJECTIVE: The aim of this study was to...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mult Scler Int
Päätekijät: Daniels, K., van der Nat, P. B., Frequin, S. T. F. M., van der Wees, P. J., Biesma, D. H., Hoogervorst, E. L. J., van de Garde, E. M. W.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313157/
https://ncbi.nlm.nih.gov/pubmed/32607256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5463451
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia